Expertise in
5
conditions

Dr. John D. Hudson

Neurology
Sleep Medicine Consultants
5508 Parkcrest Dr Ste 310, 
Austin, TX 
Accepting New Patients
Expertise in
5
conditions
Sleep Medicine Consultants
5508 Parkcrest Dr Ste 310, 
Austin, TX 

Overview

John Hudson is a Neurologist practicing medicine in Austin, Texas.

Dr. Hudson is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Restless Legs Syndrome, Obstructive Sleep Apnea, Excessive Daytime Sleepiness, and Migraine with Brainstem Aura.

He is actively involved in clinical research, co-authoring 9 peer reviewed articles and participating in 18 clinical trials. Dr. Hudson is currently accepting new patients.

Specialties

Neurology

Licenses

Psychiatry & Neurology in TX

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Oscar
  • EPO
  • HMO
  • PPO
Sendero
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
US Health and Life
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Sleep Medicine Consultants
5508 Parkcrest Dr Ste 310, Austin, TX 78731

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

18 Clinical Trials

Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Phase 2 Randomized Double-Blind Placebo-Controlled Parallel-Arm Dose Finding Study to Compare Fixed Dose Combinations of AD109 and AD504 to Atomoxetine or Placebo in Obstructive Sleep Apnea
Enrollment Status: Completed
Publish Date: August 12, 2026
Intervention Type: Drug
Study Drugs: AD109, AD504, Atomoxetine Hydrochloride
Study Phase: Phase 2
A Master Protocol to Investigate the Efficacy and Safety of Tirzepatide Once Weekly in Participants Who Have Obstructive Sleep Apnea and Obesity: A Randomized, Double-Blind, Placebo-Controlled Trial
A Master Protocol to Investigate the Efficacy and Safety of Tirzepatide Once Weekly in Participants Who Have Obstructive Sleep Apnea and Obesity: A Randomized, Double-Blind, Placebo-Controlled Trial
Enrollment Status: Completed
Publish Date: April 30, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
A Phase 2, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 mg and 4 mg SUVN-G3031 Compared to Placebo in Patients With Narcolepsy With and Without Cataplexy
Enrollment Status: Completed
Publish Date: January 13, 2025
Intervention Type: Drug
Study Drug: SUVN-G3031
Study Phase: Phase 2
A Multi-Center, Randomized, Double-Blind, Sham-Controlled Study to Evaluate the NTX100 Neuromodulation System for Patients With Medication-Refractory Primary Restless Legs Syndrome (RLS) - The RESTFUL Study
A Multi-Center, Randomized, Double-Blind, Sham-Controlled Study to Evaluate the NTX100 Neuromodulation System for Patients With Medication-Refractory Primary Restless Legs Syndrome (RLS) - The RESTFUL Study
Enrollment Status: Completed
Publish Date: October 08, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug
Study Phase: Phase 3
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
Enrollment Status: Completed
Publish Date: June 28, 2024
Intervention Type: Drug
Study Drugs: Galcanezumab, Rimegepant
Study Phase: Phase 4
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain
A 2-stage, Adaptive, Randomised, Double-blind, Placebo-controlled, Multicentre Study to Evaluate Dose and Treatment Effect of Pentosan Polysulfate Sodium Compared With Placebo in Participants With Knee Osteoarthritis Pain
Enrollment Status: Active_not_recruiting
Publish Date: April 08, 2024
Intervention Type: Drug
Study Drug: Pentosan Polysulfate Sodium
Study Phase: Phase 2/Phase 3
ImThera Medical Targeted Hypoglossal Neurostimulation Study #3
ImThera Medical Targeted Hypoglossal Neurostimulation Study #3
Enrollment Status: Completed
Publish Date: February 07, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Diabetic Peripheral Neuropathic Pain
Enrollment Status: Completed
Publish Date: November 22, 2023
Intervention Type: Drug
Study Drug: LY3526318
Study Phase: Phase 2
View 9 Less Clinical Trials

9 Total Publications

RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates.
RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates.
Journal: Sleep medicine: X
Published: May 23, 2024
Similar Doctors
Expertise in
8
conditions
Expertise in
8
conditions
Referral may be required

The Univ. Of Texas At Austin

1601 Trinity St, 
Austin, TX 
 (5.3 miles away)
512-495-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Elliot Frohman is a Neurologist practicing medicine in Austin, Texas. Dr. Frohman is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Optic Neuritis, Relapsing Multiple Sclerosis (RMS), and Transverse Myelitis. Dr. Frohman is currently accepting new patients in some locations.

Expertise in
7
conditions
Expertise in
7
conditions
Referral may be required

Ascension Seton Medical Center Austin

1201 W 38th St, 
Austin, TX 
 (3.3 miles away)
512-218-1222
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Edward Fox is a Neurologist practicing medicine in Austin, Texas. Dr. Fox is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Relapsing Multiple Sclerosis (RMS), Multiple Sclerosis (MS), Transverse Myelitis, Osteotomy, and Vertebroplasty. Dr. Fox is currently accepting new patients.

Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required

Texas Movement Disorder Specialists PLLC

204 S Interstate 35 Ste 103, 
Georgetown, TX 
 (21.8 miles away)
512-693-4041
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Soileau is a Neurologist practicing medicine in Georgetown, Texas. Dr. Soileau is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Parkinson's Disease, Movement Disorders, Essential Tremor, Deep Brain Stimulation, and Gastrostomy. Dr. Soileau is currently accepting new patients.

Frequently Asked Questions about Dr. John D. Hudson

How do I make an appointment with Dr. John D. Hudson?

You can book an appointment with Dr. John D. Hudson by calling their office at 512-420-0951. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. John D. Hudson a top-rated expert for Restless Legs Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. John D. Hudson is classified as an Distinguished expert for Restless Legs Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. John D. Hudson specialize in?

While Dr. John D. Hudson is a Neurology, they have specific expertise in Restless Legs Syndrome, Obstructive Sleep Apnea, and Excessive Daytime Sleepiness. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. John D. Hudson participate in research or clinical trials?

Yes. Dr. John D. Hudson has published 9 articles and abstracts on conditions like Restless Legs Syndrome. You can view a list of Dr. John D. Hudson's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. John D. Hudson accept my insurance?

Dr. John D. Hudson accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 512-420-0951 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hudson's expertise for a condition
ConditionClose
    View All 8 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile